p53 is activated in response to disruption of the pre-mRNA splicing machinery

N Allende-Vega1, S Dayal, U Agarwala

  • 1Division of Cancer Research, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Angus, UK.

Oncogene
|February 22, 2012
PubMed

Insights

Targeting the spliceosome, the cell's splicing machinery, activates the tumor suppressor p53. This leads to cell cycle arrest and suggests a role for p53 in cancer protection and therapy.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Biology

Background:

  • Alterations in RNA splicing are increasingly recognized as significant factors in tumor development.
  • The spliceosome, a complex molecular machine, is crucial for RNA processing, and its dysregulation is common in cancer.
  • The tumor suppressor p53 plays a critical role in cellular responses to stress and DNA damage.

Purpose of the Study:

  • To investigate the consequences of interfering with the spliceosome on the activity of the tumor suppressor p53.
  • To elucidate the mechanisms by which spliceosome modulation impacts p53 levels and function.
  • To explore the potential implications of spliceosome-mediated p53 activation in cancer therapy.

Main Methods:

  • Targeting the spliceosome using small interfering RNA (siRNA) to knock down associated proteins.
  • Utilizing the small-molecule spliceosome modulator TG003.
  • Assessing p53 accumulation, transcriptional activity, and p53-dependent cell cycle arrest.
  • Analyzing the protein levels and degradation rates of p53 repressors Mdm2 and MdmX.

Main Results:

  • Interference with the spliceosome machinery leads to the accumulation and activation of the tumor suppressor p53.
  • p53 activation was characterized by increased transcriptional activity and p53-dependent G1 cell cycle arrest.
  • Targeting the spliceosome resulted in decreased levels of MdmX and increased degradation of Mdm2, key p53 repressors.
  • These findings suggest that p53 activation is a downstream consequence of spliceosome disruption.

Conclusions:

  • Spliceosome integrity is critical for regulating p53 activity.
  • p53 activation in response to spliceosome interference may serve as a protective mechanism against oncogenic splicing defects.
  • The interplay between splicing, p53, and its repressors offers potential therapeutic strategies targeting cancer cells.
  • Understanding how spliceosome inhibitors activate p53 could enhance their selective anti-tumor efficacy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...